GI Bleeding Lower With Apixaban Versus Other DOACs in A-Fib

TUESDAY, Nov. 1, 2022 -- For patients with atrial fibrillation (AF), apixaban use is associated with a lower risk for gastrointestinal bleeding (GIB) compared with other direct oral anticoagulants (DOACs), according to a study published online Nov....
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news